(Q46371309)

21 December 2017

title

The syndromes of low-renin hypertension: "separating the wheat from the chaff". (English)

1 reference

21 December 2017

1 reference

Claudio E Kater

1

1 reference

21 December 2017

Edward G Biglieri

series ordinal

2

1 reference

21 December 2017

publication date

1 October 2004

1 reference

21 December 2017

Arquivos Brasileiros de Endocrinologia e Metabologia

published in

1 reference

21 December 2017

volume

48

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

674-681

1 reference

21 December 2017

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Hyperaldosteronism among black and white subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Editorial: Low renin "essential'' hypertension; a variant of classic primary aldosteronism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Cautions over the current epidemic of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Primary aldosteronism, a common entity? the myth persists

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Aldosterone to Renin ratio in a primary care setting: the Bussolengo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Reassessment of the predictive value of the postural stimulation test in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Primary aldosteronism: revival of a syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Treatment of hypertension with spironolactone. Double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

The current epidemic of primary aldosteronism: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000500013

10.1590/S0004-27302004000500013

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017